Bicycle Therapeutics (BCYC) Leases (2019 - 2025)
Bicycle Therapeutics' Leases history spans 7 years, with the latest figure at $15.9 million for Q4 2025.
- For Q4 2025, Leases rose 107.04% year-over-year to $15.9 million; the TTM value through Dec 2025 reached $15.9 million, up 107.04%, while the annual FY2025 figure was $15.9 million, 107.04% up from the prior year.
- Leases reached $15.9 million in Q4 2025 per BCYC's latest filing, up from $4.6 million in the prior quarter.
- In the past five years, Leases ranged from a high of $18.7 million in Q1 2023 to a low of $3.2 million in Q3 2021.
- Average Leases over 5 years is $11.0 million, with a median of $12.6 million recorded in 2023.
- Peak YoY movement for Leases: soared 1036.9% in 2021, then crashed 49.82% in 2025.
- A 5-year view of Leases shows it stood at $14.7 million in 2021, then decreased by 6.87% to $13.7 million in 2022, then dropped by 3.58% to $13.2 million in 2023, then tumbled by 41.73% to $7.7 million in 2024, then surged by 107.04% to $15.9 million in 2025.
- Per Business Quant, the three most recent readings for BCYC's Leases are $15.9 million (Q4 2025), $4.6 million (Q3 2025), and $5.8 million (Q2 2025).